ATG7 Drives Metabolic Cell-Fate Decisions in Kidney Tubule Homeostasis and Disease

Background: Specialized epithelial cells must coordinate metabolic pathways with differentiation cues to fulfil their functions and maintain homeostasis. A paradigm for this concept is provided by proximal tubule (PT) cells in the kidney, which require high energy to recover ultrafiltered proteins and solutes via endocytosis and lysosomal degradation. Simultaneously, autophagy recycles intracellular components to support energy metabolism and homeostasis. Central to autophagy biogenesis is ATG7 — a conserved E1-like enzyme that conjugates ATG12 to ATG5 and lipidates MAP1LC3-I into MAP1LC3-II, a bona fide biosensor of autophagy levels in cells and tissues. While ATG7-dependent autophagy is recognized for its role in resilience in response to cellular stressors, its basal function in shaping the metabolic PT cell-fate specialization remains poorly understood. Methods: We integrated genetically engineered models (mouse, C. elegans, and zebrafish) with physiologically relevant PT cell cultures, functional lipid metabolism assays (e.g., pulse-chase using fluorescent lipid droplet and fatty acid probes), multi-omics analyses, and human genetics to investigate the role of ATG7 in PT cell-fate decisions and determination. Results: In mice, PT-specific deletion of ATG7 forces differentiated cells into anabolic, proliferative states, leading to the appearance in the urine of essential nutrients and causing proximal tubulopathy. Mechanistically, loss of ATG7 impairs the clearance of lipid droplets, restricts fatty-acid (FA) metabolism, and depletes cellular energy required for transport and reabsorptive functions. In zebrafish pronephros, re-expression of wild-type ATG7 rescues reabsorption in atg7 mutants, whereas inhibiting FA oxidation triggers dysfunction. In humans, ATG7 variants associate with cardio-renal-metabolic health and increased kidney disease risk, whereas low ATG7 levels predict poor survival in clear cell renal carcinoma. Conclusion: Taken together, these findings establish a conserved paradigm coupling ATG7/autophagy and lipid energy metabolism to epithelial cell-fate specialization in the kidney tubule, thus carrying implications for health, disease, and therapeutic discovery.

Authors

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2025-10-01
DOI
https://doi.org/10.1681/asn.2025gft0h4xa
Primary Topic
Autophagy in Disease and Therapy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ATG7 Drives Metabolic Cell-Fate Decisions in Kidney Tubule Homeostasis and Disease

Daniela Nieri, Svenja Aline Keller, Alessandro Luciani, Olivier Devuyst et al.
Journal of the American Society of Nephrology
Autophagy in Disease and Therapy
article

ATG7 Drives Metabolic Cell-Fate Decisions in Kidney Tubule Homeostasis and Disease

Daniela Nieri, Svenja Aline Keller, Alessandro Luciani, Olivier Devuyst, Louise Pierre, Zhiyong Chen
article en

Abstract

Background: Specialized epithelial cells must coordinate metabolic pathways with differentiation cues to fulfil their functions and maintain homeostasis. A paradigm for this concept is provided by proximal tubule (PT) cells in the kidney, which require high energy to recover ultrafiltered proteins and solutes via endocytosis and lysosomal degradation. Simultaneously, autophagy recycles intracellular components to support energy metabolism and homeostasis. Central to autophagy biogenesis is ATG7 — a conserved E1-like enzyme that conjugates ATG12 to ATG5 and lipidates MAP1LC3-I into MAP1LC3-II, a bona fide biosensor of autophagy levels in cells and tissues. While ATG7-dependent autophagy is recognized for its role in resilience in response to cellular stressors, its basal function in shaping the metabolic PT cell-fate specialization remains poorly understood. Methods: We integrated genetically engineered models (mouse, C. elegans, and zebrafish) with physiologically relevant PT cell cultures, functional lipid metabolism assays (e.g., pulse-chase using fluorescent lipid droplet and fatty acid probes), multi-omics analyses, and human genetics to investigate the role of ATG7 in PT cell-fate decisions and determination. Results: In mice, PT-specific deletion of ATG7 forces differentiated cells into anabolic, proliferative states, leading to the appearance in the urine of essential nutrients and causing proximal tubulopathy. Mechanistically, loss of ATG7 impairs the clearance of lipid droplets, restricts fatty-acid (FA) metabolism, and depletes cellular energy required for transport and reabsorptive functions. In zebrafish pronephros, re-expression of wild-type ATG7 rescues reabsorption in atg7 mutants, whereas inhibiting FA oxidation triggers dysfunction. In humans, ATG7 variants associate with cardio-renal-metabolic health and increased kidney disease risk, whereas low ATG7 levels predict poor survival in clear cell renal carcinoma. Conclusion: Taken together, these findings establish a conserved paradigm coupling ATG7/autophagy and lipid energy metabolism to epithelial cell-fate specialization in the kidney tubule, thus carrying implications for health, disease, and therapeutic discovery.

Journal of the American Society of NephrologyVol. 36(10S)
University of Zurich (CH)
Openalex Percentile: Top 51%
Autophagy in Disease and Therapy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.